A Phase 1/2 Trial (CheckCell-2) in Patients with Metastatic Non-small Cell Lung Cancer (NSCLC)Administering Tumor-Infiltrating Lymphocytes (TILs) in Which the Gene Encoding CISH was InactivatedUsing the CRISPR/Cas9 System

Project: Research project

Project Details

Description

A Phase 1/2 Trial (CheckCell-2) in Patients with Metastatic Non-small Cell Lung Cancer (NSCLC) Administering Tumor-Infiltrating Lymphocytes (TILs) in Which the Gene Encoding CISH was Inactivated Using the CRISPR/Cas9 System
StatusActive
Effective start/end date10/10/22 → 10/31/27

Funding

  • INTIMA BIOSCIENCES, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint